• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Double Jeopardy: Precapillary Pulmonary Hypertension Increases the Risk of Hospitalization and Death from COVID-19.

作者信息

Alba George A

机构信息

Division of Pulmonary and Critical Care Massachusetts General Hospital Boston, Massachusetts.

出版信息

Am J Respir Crit Care Med. 2022 Sep 1;206(5):526-528. doi: 10.1164/rccm.202205-0884ED.

DOI:10.1164/rccm.202205-0884ED
PMID:35584345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9716902/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a23/9716902/9d7460cf4cfc/rccm.202205-0884EDf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a23/9716902/9d7460cf4cfc/rccm.202205-0884EDf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a23/9716902/9d7460cf4cfc/rccm.202205-0884EDf1.jpg

相似文献

1
Double Jeopardy: Precapillary Pulmonary Hypertension Increases the Risk of Hospitalization and Death from COVID-19.双重风险：毛细血管前性肺动脉高压增加COVID-19住院和死亡风险。
Am J Respir Crit Care Med. 2022 Sep 1;206(5):526-528. doi: 10.1164/rccm.202205-0884ED.
2
Right Atrial Function Predicts Clinical Outcome in Patients with Precapillary Pulmonary Hypertension.右心房功能可预测毛细血管前性肺动脉高压患者的临床转归。
J Am Soc Echocardiogr. 2018 Oct;31(10):1137-1145. doi: 10.1016/j.echo.2018.05.015. Epub 2018 Aug 6.
3
Differentiating Precapillary From Postcapillary Pulmonary Hypertension.鉴别毛细血管前性与毛细血管后性肺动脉高压。
Circulation. 2019 Aug 27;140(9):712-714. doi: 10.1161/CIRCULATIONAHA.119.040295. Epub 2019 Aug 26.
4
Echocardiographic and Hemodynamic Predictors of Survival in Precapillary Pulmonary Hypertension: Seven-Year Follow-Up.毛细血管前性肺动脉高压患者生存的超声心动图和血流动力学预测因素：七年随访
Circ Cardiovasc Imaging. 2015 Jun;8(6). doi: 10.1161/CIRCIMAGING.114.002107.
5
Clinical Relevance of Fluid Challenge in Patients Evaluated for Pulmonary Hypertension.针对肺动脉高压患者进行液体负荷试验的临床意义
Chest. 2017 Jan;151(1):119-126. doi: 10.1016/j.chest.2016.08.1439. Epub 2016 Aug 26.
6
High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension.毛细血管前性肺动脉高压中抗磷脂抗体的高患病率。
J Rheumatol. 1996 Feb;23(2):286-90.
7
A simple echocardiographic score for the diagnosis of pulmonary vascular disease in heart failure.一种用于诊断心力衰竭中肺血管疾病的简单超声心动图评分。
J Cardiovasc Med (Hagerstown). 2017 Apr;18(4):237-243. doi: 10.2459/JCM.0000000000000485.
8
Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort.合并肺动脉高压及楔压升高的系统性硬化症患者的临床特征与生存情况：来自PHAROS队列的观察结果
Respirology. 2017 Oct;22(7):1386-1392. doi: 10.1111/resp.13067. Epub 2017 May 12.
9
Human atrial natriuretic peptide secretion in precapillary pulmonary hypertension. Clinical study in patients with COPD and interstitial fibrosis.
Chest. 1988 Jan;93(1):31-7. doi: 10.1378/chest.93.1.31.
10
Noninvasive Prediction of Elevated Wedge Pressure in Pulmonary Hypertension Patients Without Clear Signs of Left-Sided Heart Disease: External Validation of the OPTICS Risk Score.无创预测无左心疾病明确征象的肺动脉高压患者的楔压升高：OPTICS 风险评分的外部验证。
J Am Heart Assoc. 2020 Aug 4;9(15):e015992. doi: 10.1161/JAHA.119.015992. Epub 2020 Jul 31.

引用本文的文献

1
Respiratory long COVID in aged hamsters features impaired lung function post-exercise with bronchiolization and fibrosis.老年仓鼠的长新冠呼吸系统特征为运动后肺功能受损，并伴有细支气管化和纤维化。
Nat Commun. 2025 Feb 28;16(1):2080. doi: 10.1038/s41467-025-57267-x.

本文引用的文献

1
Pulmonary endothelial NEDD9 and the prothrombotic pathophenotype of acute respiratory distress syndrome due to SARS-CoV-2 infection.肺内皮NEDD9与SARS-CoV-2感染所致急性呼吸窘迫综合征的血栓前病理表型
Pulm Circ. 2022 May 11;12(2):e12071. doi: 10.1002/pul2.12071. eCollection 2022 Apr.
2
COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study.COVID-19 与肺动脉高压患者：一项全国性前瞻性队列研究。
Am J Respir Crit Care Med. 2022 Sep 1;206(5):573-583. doi: 10.1164/rccm.202112-2761OC.
3
Risk Factors for Severe COVID-19 Outcomes Among Persons Aged ≥18 Years Who Completed a Primary COVID-19 Vaccination Series - 465 Health Care Facilities, United States, December 2020-October 2021.
≥18 岁完成初级 COVID-19 疫苗接种系列的人群中严重 COVID-19 结局的危险因素-465 家医疗保健机构，美国，2020 年 12 月-2021 年 10 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 7;71(1):19-25. doi: 10.15585/mmwr.mm7101a4.
4
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.新冠肺炎危重症患者的肝素治疗性抗凝。
N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4.
5
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.COVID-19 非危重症患者的肝素治疗性抗凝。
N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4.
6
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.新冠病毒病（COVID-19）合并D-二聚体浓度升高住院患者的治疗性与预防性抗凝治疗（ACTION）：一项开放标签、多中心、随机对照试验
Lancet. 2021 Jun 12;397(10291):2253-2263. doi: 10.1016/S0140-6736(21)01203-4. Epub 2021 Jun 4.
7
Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study.抗凝治疗是 COVID-19 的潜在保护因素：一项法国多中心队列研究的启示
J Am Heart Assoc. 2021 Apr 20;10(8):e018624. doi: 10.1161/JAHA.120.018624. Epub 2021 Feb 8.
8
COVID-19 in Pulmonary Artery Hypertension (PAH) Patients: Observations from a Large PAH Center in New York City.肺动脉高压（PAH）患者中的新型冠状病毒肺炎（COVID-19）：来自纽约市一家大型PAH中心的观察结果
Diagnostics (Basel). 2021 Jan 15;11(1):128. doi: 10.3390/diagnostics11010128.
9
Causes and Circumstances of Death among Patients Hospitalized with COVID-19: A Retrospective Cohort Study.COVID-19住院患者的死亡原因及情况：一项回顾性队列研究
Ann Am Thorac Soc. 2021 Jun;18(6):1076-1079. doi: 10.1513/AnnalsATS.202011-1381RL.
10
COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey.肺动脉高压和慢性血栓栓塞性肺动脉高压中的新型冠状病毒肺炎：一项参考中心调查
ERJ Open Res. 2020 Nov 2;6(4). doi: 10.1183/23120541.00520-2020. eCollection 2020 Oct.